Render Target: STATIC
Render Timestamp: 2024-12-23T12:15:05.241Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-09-30 01:59:22.388
Product last modified at: 2024-12-06T14:30:09.801Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

ALOX15 (E5D1C) Rabbit mAb #82129

Filter:
  • WB
  • F

    Supporting Data

    REACTIVITY H M
    SENSITIVITY Endogenous
    MW (kDa) 75
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • F-Flow Cytometry 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Flow Cytometry (Fixed/Permeabilized) 1:500 - 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    ALOX15 (E5D1C) Rabbit mAb recognizes endogenous levels of total ALOX15 protein. This antibody does not cross-react with ALOX15B protein.

    Species Reactivity:

    Human, Mouse

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with recombinant protein specific to a region of human ALOX15 protein.

    Background

    Polyunsaturated fatty acid lipoxygenase ALOX15, also known as arachidonate 15-lipoxygenase (15-LOX, 15-LOX-1), catalyzes oxygenation of polyunsaturated fatty acids to corresponding hydroperoxides (1,2). Studies show that the small scaffolding protein PEBP1 associates with ALOX15 and polyunsaturated fatty acid lipoxygenase ALOX15B to change their substrate specificity, resulting in the conversion of polyunsaturated phosphatidylethanolamines (PE) to hydroperoxy-PE. Hydroperoxy-PE, when not sufficiently reduced by GPX4, causes ferroptosis (3). In addition, a loss-of-function mutation in ALOX15 leads to protection against nasal polyps and chronic rhinosinusitis (4). Furthermore, ALOX15-positive macrophages contribute to the pathogenesis of a subtype of chronic rhinosinusitis (5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.